Talk to Robyn

00 1 718 213 49 04

All regions

Clinical Trial Research Reports, May 2013

You might be interested in: medical equipment, therapeutics, cancer, more »


 

1-20 of about 2 500 reports for Clinical Trial
Dyskinesia Global Clinical Trials Review, H1, 2013

Dyskinesia Global Clinical Trials Review, H1, 2013

  • $ 2 500
  • Industry report
  • April 2013
  • by Global Data

Dyskinesia Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, ?Dyskinesia Global Clinical Trials Review, H1, 2013" provides data on the Dyskinesia clinical trial scenario. ...

France Phase I Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

United Kingdom Phase I Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Australia Phase I Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2011
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Singapore Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

South Korea Phase I Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

United States Phase I Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Singapore Phase Ii Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Brazil Phase Ii Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Canada Phase Ii Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2010
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Australia Total Clinical Trials

  • $ 250
  • Industry data
  • January 2013

Yearly, From 2006 To 2011
By Business Monitor International
Source: ClinicalTrials.gov, BMI. N.B. Sourced by date of initial registration.

Mymetics Corporation (Symbol:MYMX) SWOT Analysis, Strategy, Revenues and Profits

Mymetics Corporation (Symbol:MYMX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Medispec LTD - Product Pipeline Analysis, 2013 Update

Medispec LTD - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary Medispec LTD, (Medispec) is a medical device manufacturing company. The company develops, manufactures and markets non invasive medical devices for the cardiovascular, urology, orthopedic, physiotherapy, ...

JetGuide Ltd. - Product Pipeline Analysis, 2013 Update

JetGuide Ltd. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary JetGuide Ltd. (JetGuide) is a medical device company. The company develops systems for real-time intraoperative monitoring with feedback throughout processes of surgical procedures of bone drilling ...

Perfint Healthcare Pvt. Ltd. - Product Pipeline Analysis, 2013 Update

Perfint Healthcare Pvt. Ltd. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary Perfint Healthcare Pvt. Ltd. (Perfint) is a medical device company. The company develops medical devices for the healthcare market. Its products include Maxio, Robio EX, Robio EZ and Robio. Robio ...

CollPlant Ltd. - Product Pipeline Analysis, 2013 Update

CollPlant Ltd. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary CollPlant Ltd. (CollPlant) is a medical device company. The company develops regenerative medicine by utilizing proprietary processing technologies for human collagen and other recombinant proteins. ...

Teknimed S.A. - Product Pipeline Analysis, 2013 Update

Teknimed S.A. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary Teknimed S.A. (Teknimed) is a medical device company. The company develops and manufactures orthopedic products. Its products include acrylic bone cements, resorbable obturators, bone substitutes, ...

Integra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis, 2013 Update

Integra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary Integra LifeSciences Holdings Corporation (Integra) is a medical technology company. The company categorized its products into orthopedics, neurosurgery and instruments. Its orthopedics products ...

Jemo Spine, LLC. - Product Pipeline Analysis, 2013 Update

Jemo Spine, LLC. - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary Jemo Spine, LLC. (Jemo Spine) is a medical device company. The company designs, develops, manufactures and markets orthopedic products for the spine market. It designs and develops spinal fusion ...

Histogenics Corporation - Product Pipeline Analysis, 2013 Update

Histogenics Corporation - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary Histogenics Corporation (Histogenics) is a regenerative medicine company. The company develops and manufactures tissue regeneration products for the orthopedic markets. Its products include vericart ...

» Download Public Reports

About 3 900 reports for Clinical Trial
The Future of Clinical Trial

The Future of Clinical Trial

  • Industry report
  • January 2013
  • 9 pages


» Read our Company Profiles

About 100 Companies for Clinical Trial

Pfizer Inc.

United States

GlaxoSmithKline P.L.C.

United States

GlaxoSmithKline PLC

United Kingdom

Novartis Inc.

Switzerland

AstraZeneca PLC

United Kingdom

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.